Migraine is a a severe headache disorder characterized by recurrent attacks of moderate to severe throbbing and pulsating pain usually on one side of the head.The exact mechanisms behind migraines are not fully understood

Recent WHO data suggests that 1 in 8 people in the world are living with obesity

The FDA recently granted approval to Lifileucel as the first one-time cell therapy and the first tumor-infiltrating lymphocytes (TIL) therapy for a solid tumor, melanoma, which is an advanced skin cancer. TIL technology has taken nearly four decades to reach maturity. TIL therapy is a type of treatment in which tumor-infiltrating lymphocytes (a type of immune cell that can recognize and kill cancer cells) are removed from a patient’s tumor and grown in large numbers in a laboratory.

55 Novel therapeutics were approved by the U.S. FDA’s Center for Drug Evaluation & Research in 2023, the second highest in the past 30 years.